Core Viewpoint - Dr. Pan Honghui, the Executive Director and Chairman of Sanofi Pharmaceutical-B (02257), has purchased 100,000 shares of the company at an average price of approximately HKD 6.83 per share, totaling around HKD 683,000, indicating confidence in the company's growth prospects [1] Summary by Relevant Sections - Share Purchase Details - Dr. Pan acquired 100,000 shares at an average price of HKD 6.83 per share, amounting to HKD 683,000 [1] - Following the purchase, Dr. Pan holds a total of 17,627,696 shares, representing 16.44% of the company's issued share capital as of the announcement date [1] - Outlook and Future Intentions - Dr. Pan expressed strong confidence in the overall development prospects and potential growth of the group [1] - He does not rule out the possibility of further increasing his shareholding in the company at an appropriate time, in compliance with applicable laws and regulations [1]
圣诺医药-B(02257)获主席潘洪辉增持10万股